Sancuso FDA Approval History
FDA Approved: Yes (First approved September 12, 2008)
Brand name: Sancuso
Generic name: granisetron
Dosage form: Transdermal Patch
Company: ProStrakan Group plc
Treatment for: Nausea/Vomiting, Chemotherapy Induced
Sancuso (granisetron transdermal system) is an anti-emetic transdermal delivery system indicated for the control of nausea and vomiting in patients receiving moderately and/or highly nausea-inducing chemotherapy.
Development Timeline for Sancuso
|Sep 15, 2008||FDA Approves Sancuso, the First and Only Patch for Preventing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy|
|Jun 2, 2008||ProStrakan Presents Update on Sancuso US Regulatory Review Status|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.